The recently released Hormonal Contraceptive Market Report 2024, delivers an in-depth analysis of the market. This comprehensive evaluation includes size, product specifications, cost structures, industry connections, and an overview of the market landscape. Additionally, the report offers detailed insights into the Hormonal Contraceptive market’s size, volume, and forecasts across various product types, applications, and end-users. With its expert insights, the report serves as a crucial guide for enterprises seeking a strategic comprehension of the constantly evolving technology sector.
Who are the Largest Manufacturers of Hormonal Contraceptive Market Globally?
- Pfizer Inc.
- Bayer AG
- Merck & Co., Inc.
- Allergan plc
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Novartis International AG
- Lupin Pharmaceuticals, Inc.
- HLL Lifecare Limited
- Mithra Pharmaceuticals
- Ferring Pharmaceuticals
- Afaxys, Inc.
- Agile Therapeutics
- Apothecus Pharmaceutical Corp.
- Piramal Enterprises Ltd.
- TherapeuticsMD, Inc.
- CooperSurgical, Inc.
- Watson Pharmaceuticals, Inc.
- Glenmark Pharmaceuticals Ltd.
- Janssen Pharmaceutical NVHormonal Contraceptive Market Recent Developments
- In July 2022, Mayne Pharma Group Limited and Mithra Pharmaceuticals, SA launched NEXTSTELLIS in Australia. NEXTSTELLIS is an oral contraceptive that combines two active ingredients: estetrol (E4) and drospirenone. Estetrol is a natural estrogen produced by the fetal liver during pregnancy, and it has a unique profile that makes it different from other estrogens used in hormonal contraceptives. Estetrol has a weaker binding affinity to the estrogen receptor than other estrogens, which means it is less likely to stimulate breast tissue and other estrogen-sensitive tissues. This makes it a promising candidate for use in hormonal contraceptives.
- In January 2022, the National Population and Family Planning Agency in Indonesia launched a new birth control pill called Progestin, which is safe for nursing mothers to use. The goal of this initiative is to encourage exclusive breastfeeding, which can help prevent infant stunting and promote healthy growth and development.
- In July 2022, the Organon Group of companies announced that they had entered into a license agreement with Cirqle Biomedical for a novel investigational non-hormonal on-demand preventive product. Organon is a global healthcare company that focuses on women’s health, and the agreement reflects its commitment to developing innovative options for women.
- In May 2021, Allergan announced that it had received approval from the European Commission for its new contraceptive patch called Twirla. Twirla is a once-weekly contraceptive patch that contains both estrogen and progestin.
- In April 2021, Merck & Co. announced that the U.S. Food and Drug Administration (FDA) had approved a new long-acting injectable contraceptive called Annovera. Annovera is a small, flexible ring that is inserted into the vagina and provides contraceptive protection for up to a year.
Hormonal Contraceptive Market’s Drivers and Restraints:
The report delves into crucial aspects of the Hormonal Contraceptive market, including production costs, supply chain dynamics, and raw material dependencies. It offers an analysis of how the COVID-19 pandemic has affected the industry and provides actionable recommendations for businesses to navigate evolving market conditions effectively. Key market restraints, such as economic challenges in emerging nations and obstacles within the business landscape, are identified and explored in detail. Understanding these risks enables businesses to devise strategies aimed at mitigating challenges and ensuring sustained success in this dynamic industry.
Get Sample Report Copy of Hormonal Contraceptive Market Report
Hormonal Contraceptive Market Size And Scope
The Hormonal Contraceptive market has experienced notable growth in recent years, propelled by the rising demand for power electronics across various sectors, including automotive, telecommunications, and renewable energy. This market is poised for further expansion as the global adoption of electric vehicles and renewable energy sources accelerates. Hormonal Contraceptive s are highly valued for their exceptional thermal conductivity, electrical insulation, and mechanical strength, making them indispensable in power modules and electronic components. With ongoing advancements in technology and manufacturing, the applications of Hormonal Contraceptive s are expected to broaden, extending their reach into an even wider array of uses in the near future.
Regional Segmentation:
- North America: U.S., Canada and Mexico
- Europe: Germany, France, U.K., Italy, Spain, and Rest of Europe
- Asia Pacific: China, India, Japan, South Korea, Southeast Asia, and Rest of Asia Pacific
- South America: Brazil, Argentina, and Rest of Latin America
- Middle East & Africa: GCC Countries, South Africa, and Rest of Middle East & Africa
Why You Should Purchase This Report:
- Discovering Valuable Connections: Uncover potential suppliers and partnership opportunities highlighted in the report.
- Market Dynamics and Trends: Grasp a complete understanding of the global Hormonal Contraceptive market’s dynamics and trends.
- In-Depth Market Analysis: Explore the latest market trends and thorough competitive analysis, along with other key insights about the global market.
- Spotting Potential Collaborators: Learn about potential future partners, suppliers, or affiliates outlined in the report.
- Strategic Mergers and Acquisitions: Strategically plan mergers and acquisitions by identifying top manufacturers in the industry.
- Identifying Emerging Competitors: Recognize emerging players who have strong product offerings, allowing you to devise effective strategies to stay competitive.
- Targeting New Clients or Partners: Identify potential new clients or partners within your desired audience.
- Strategizing Based on Industry Leaders: Develop tactical plans by understanding the key areas of focus for leading companies.
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
Our Other Reports:
Sports Medicine Market to Generate a CAGR of 5.6% by 2031, Driven by High Youth Sports Participation
Sports Medicine Market to Generate a CAGR of 5.6% by 2031, Driven by High Youth Sports Participation
Genomics Market is Predicted to Expand at an Impressive 19.4% CAGR through 2031
Genomics Market is Predicted to Expand at an Impressive 19.4% CAGR through 2031
Genomics Market is Predicted to Expand at an Impressive 19.4% CAGR through 2031
Synergy between Medicine and Technological Drives Sports Medicine Market at 5.6% CAGR through 2031